,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,6.22046825367037e-26,5.11322490451704e-23
2,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Down,1.15958769485508e-08,4.76590542585439e-06
3,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,6.4875190112373e-08,1.77758020907902e-05
4,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,2.09817919835702e-07,4.31175825262367e-05
5,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,6.06242781490171e-07,9.9666313276984e-05
6,WP_PROSTAGLANDIN_SIGNALING,22,Down,8.65013261532235e-07,0.000118506816829916
7,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Down,1.59850766041079e-06,0.000187710470979668
8,WP_SPINAL_CORD_INJURY,66,Down,3.99400160562194e-06,0.000410383664977655
9,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,2.94042021556902e-05,0.00268558379688637
10,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,4.54818875646093e-05,0.00347604433696154
11,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,4.70329613431948e-05,0.00347604433696154
12,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,5.07451728023582e-05,0.00347604433696154
13,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.000111507742531459,0.00705072033545074
14,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.000154016438428,0.00904296517055829
15,WP_MEVALONATE_PATHWAY,7,Down,0.000179043802582357,0.00913744436133342
16,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.00018590437897889,0.00913744436133342
17,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.000189286450847002,0.00913744436133342
18,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.000200090022510951,0.00913744436133342
19,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.000211959506972649,0.00917003761744828
20,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.000234231504192185,0.00919968214650658
21,WP_HYPERTROPHY_MODEL,13,Down,0.000240167732935794,0.00919968214650658
22,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.000249395120485724,0.00919968214650658
23,WP_COMPLEMENT_ACTIVATION,12,Up,0.000257412030863323,0.00919968214650658
24,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.000282559297188502,0.00967765592870621
25,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.00031483113088871,0.0103516475836208
26,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.000358602070459587,0.0113373423814531
27,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.000402457314184748,0.0121284554110155
28,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.000437773510042007,0.0121284554110155
29,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.000447448860972225,0.0121284554110155
30,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.000449751684651529,0.0121284554110155
31,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0004573991700018,0.0121284554110155
32,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.000750361672076022,0.0192749154514528
33,WP_GASTRIN_SIGNALING,93,Down,0.0008599718061467,0.0214211158985632
34,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.0011108040803928,0.0265194781415677
35,WP_MAPK_SIGNALING,163,Down,0.00112917486004242,0.0265194781415677
36,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.00116446251143628,0.0265885606777952
37,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00123855633302623,0.027424306670539
38,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.00129491680736391,0.027424306670539
39,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.00130115323619346,0.027424306670539
40,WP_FOCAL_ADHESION,119,Down,0.00166624719682029,0.0342413798946569
41,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.00182204044927775,0.0365296890074709
42,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.00196767950114147,0.0376462739890067
43,WP_IL1_SIGNALING,54,Down,0.00196933063446142,0.0376462739890067
44,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.00209765073321469,0.0391879296068744
45,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Down,0.00222416259151171,0.0406280366716139
46,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.00236506678904894,0.0422627152303962
47,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.00259844390368805,0.0454451252942889
48,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.00272938320251711,0.0467406873431055
49,WP_PDGF_PATHWAY,37,Down,0.0028327805457602,0.0475213389513242
50,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.00289393483254324,0.0475762886470109
51,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Down,0.00300489760023071,0.0479974524479966
52,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.00303633519135745,0.0479974524479966
53,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.00311797343642029,0.0482884736849369
54,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,49,Down,0.0031722354975506,0.0482884736849369
55,WP_AXON_GUIDANCE,37,Down,0.00336344862031563,0.0493781944381563
56,WP_PROTEASOME_DEGRADATION,57,Down,0.00336396458459459,0.0493781944381563
57,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.00357055831343916,0.0514912093622279
58,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00371954400067123,0.0527149166991681
59,WP_ASPIRIN_AND_MIRNAS,8,Down,0.00385116407474955,0.0536552011770192
60,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.00419184350587541,0.0574282560304931
61,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.00537256915740029,0.0723975712685744
62,WP_IL26_SIGNALING,31,Down,0.00560693751362519,0.0743371392935469
63,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.00601782386071007,0.0785182732302171
64,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.00647322445598924,0.0831404766066118
65,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.00714982689012421,0.0889192885641954
66,WP_TAMOXIFEN_METABOLISM,2,Up,0.00723686007634786,0.0889192885641954
67,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Down,0.00724767923820084,0.0889192885641954
68,WP_CHEMOKINE_SIGNALING,110,Down,0.00738046333386178,0.0892167773593292
69,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.00775979959045905,0.0924428299037295
70,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.00787309422807031,0.0924526207924827
71,WP_HEART_DEVELOPMENT,17,Down,0.00822326873197102,0.0952046041926786
72,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.0088149082763297,0.100636869488097
73,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,15,Down,0.00929770862487761,0.102002090110739
74,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Down,0.00931658924263308,0.102002090110739
75,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.00935405702235559,0.102002090110739
76,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,30,Down,0.00951590946446904,0.102002090110739
77,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.00973437974817629,0.102002090110739
78,WP_G13_SIGNALING,29,Down,0.00991168820968227,0.102002090110739
79,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0099705004405912,0.102002090110739
80,WP_CHOLESTEROL_METABOLISM,53,Down,0.00999242335658801,0.102002090110739
81,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.0100513008503283,0.102002090110739
82,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Down,0.0107103822144807,0.107365050979307
83,WP_OSTEOBLAST_SIGNALING,3,Down,0.0108561719927918,0.107515341904516
84,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.0113528990357314,0.108248663169579
85,WP_VEGFAVEGFR2_SIGNALING,342,Down,0.0113770395268776,0.108248663169579
86,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0115038990116128,0.108248663169579
87,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.0115891197950606,0.108248663169579
88,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.0116368022353513,0.108248663169579
89,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.0117203540414751,0.108248663169579
90,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.0122984952228293,0.112127140697742
91,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.0124131019507232,0.112127140697742
92,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.0131122678366625,0.117155262627572
93,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.0133770679481346,0.118236019928674
94,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.0139071084461048,0.120670816206991
95,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.0139461405592021,0.120670816206991
96,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.0143544627890699,0.122910087631411
97,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.014661879759361,0.123485766342792
98,WP_PRION_DISEASE_PATHWAY,28,Down,0.0147578991626961,0.123485766342792
99,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.0154855878636368,0.123485766342792
100,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.0154955593465349,0.123485766342792
101,WP_LUNG_FIBROSIS,33,Down,0.015585977853686,0.123485766342792
102,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0156699304426766,0.123485766342792
103,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.0157419081489316,0.123485766342792
104,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.0157757692576243,0.123485766342792
105,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.0158800011373485,0.123485766342792
106,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.0159239552704816,0.123485766342792
107,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0170474506408822,0.130962658194441
108,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.0173031115368518,0.131183576251209
109,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.0173953890649414,0.131183576251209
110,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.0182851231533071,0.135476591158726
111,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.0182942842075652,0.135476591158726
112,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.0185944134992296,0.13588708198631
113,WP_RETT_SYNDROME,32,Down,0.0186803409543224,0.13588708198631
114,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0191164630709326,0.137410500930005
115,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.0193110166470332,0.137410500930005
116,WP_TNFALPHA_SIGNALING,84,Down,0.0193912629049642,0.137410500930005
117,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.0198243742134661,0.139278936781788
118,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.0206395505642682,0.143028248882506
119,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.0207060360304358,0.143028248882506
120,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0221445348915064,0.15158526139004
121,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.0229428032918562,0.15158526139004
122,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.0230123785468965,0.15158526139004
123,WP_NAD_METABOLISM,12,Down,0.0230378485080645,0.15158526139004
124,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.0230473740772389,0.15158526139004
125,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.0230512867077311,0.15158526139004
126,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,91,Down,0.0233647317490257,0.152427059505548
127,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0247648972828619,0.158655820418014
128,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.0248747374711027,0.158655820418014
129,WP_CCL18_SIGNALING,20,Down,0.0250515694671113,0.158655820418014
130,WP_SELENIUM_MICRONUTRIENT_NETWORK,49,Down,0.0250915531074717,0.158655820418014
131,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,41,Down,0.0252864163561968,0.158667436983159
132,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0257544536604635,0.160380006885613
133,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.0266548398180602,0.164738934815379
134,WP_NPHP1_DELETION_SYNDROME,10,Down,0.028043884981191,0.170729356270123
135,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.0281114597334744,0.170729356270123
136,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.0282471927648865,0.170729356270123
137,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.0285849418981706,0.171509651389024
138,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0293526872822859,0.174160523557601
139,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0296254530503207,0.174160523557601
140,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0296623762750172,0.174160523557601
141,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,107,Down,0.0300112345615122,0.174227964570223
142,WP_NOTCH_SIGNALING_WP268,35,Down,0.0300977749014253,0.174227964570223
143,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.0303746643535239,0.174601217472704
144,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.0307680720578422,0.175634411330182
145,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Down,0.0313043167273891,0.177463092068371
146,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0327179103990385,0.18347952523125
147,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.0328120318844206,0.18347952523125
148,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.0339180757261772,0.186263133443184
149,WP_AMINO_ACID_METABOLISM,59,Down,0.0339772418749151,0.186263133443184
150,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.0342013116268858,0.186263133443184
151,WP_AGERAGE_PATHWAY,54,Down,0.0343827920705585,0.186263133443184
152,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.0344428178629732,0.186263133443184
153,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.0356798001224188,0.191691475167505
154,WP_SYNAPTIC_VESICLE_PATHWAY,23,Down,0.0362057878272709,0.193254270091017
155,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.0367716563170863,0.194582795545445
156,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.0371146326794936,0.194582795545445
157,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.0371648405117212,0.194582795545445
158,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.0383858509245506,0.199703604177092
159,WP_NOTCH_SIGNALING_WP61,49,Down,0.0390275323421634,0.201764978523637
160,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0405293742225133,0.208219660068162
161,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.0413803524398211,0.210548197298931
162,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0414949001975996,0.210548197298931
163,WP_SLEEP_REGULATION,11,Up,0.0425168218633931,0.21317005706183
164,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0425302790245014,0.21317005706183
165,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Down,0.0446797407758289,0.220423629166016
166,WP_ALZHEIMERS_DISEASE,184,Down,0.0449318354598815,0.220423629166016
167,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.0449318354598815,0.220423629166016
168,WP_ANGIOGENESIS,14,Down,0.0451136720458921,0.220423629166016
169,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.0454691951364302,0.220423629166016
170,WP_SPHINGOLIPID_PATHWAY,20,Down,0.0457032571425429,0.220423629166016
171,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.0459639985573194,0.220423629166016
172,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.0461227058595556,0.220423629166016
173,WP_ENDOTHELIN_PATHWAYS,12,Down,0.0465828760375802,0.221335977473358
174,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.0469868623143152,0.221972418519351
175,WP_CORI_CYCLE,11,Down,0.0476396402822059,0.223770196068419
176,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.0484772922478366,0.225684307100923
177,WP_HISTONE_MODIFICATIONS,37,Up,0.0485962559085929,0.225684307100923
178,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.0494903674217167,0.227713473996566
179,WP_NETRINUNC5B_SIGNALING,35,Down,0.0495872406878166,0.227713473996566
180,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.050043247198017,0.228530828870944
181,WP_MAPK_CASCADE,30,Down,0.0504920349542124,0.229306368687086
182,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.0515993324273592,0.232762442730484
183,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.0518193759363487,0.232762442730484
184,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.053633250179237,0.239600715474635
185,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.0546452452374338,0.241519298157164
186,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.0547672928166818,0.241519298157164
187,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0549441712352673,0.241519298157164
188,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.0565968975635554,0.247460903176822
189,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.0576684672844035,0.250812064062326
190,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0591587418734097,0.254832809486166
191,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.0596589461739018,0.254832809486166
192,WP_NEUROINFLAMMATION,10,Down,0.0599467935137968,0.254832809486166
193,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.0602541146858588,0.254832809486166
194,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.0602541146858588,0.254832809486166
195,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.0604530387467182,0.254832809486166
196,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.0626093036216263,0.262575752943759
197,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.0630621429200273,0.263132393300825
198,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.0639715388474353,0.264137317552922
199,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.0641368094394508,0.264137317552922
200,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.0642669872391538,0.264137317552922
201,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0646222614401163,0.264276113949132
202,WP_RANKLRANK_SIGNALING,48,Down,0.0653587203827358,0.265964693834697
203,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.0657296756821136,0.266156617786687
204,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.0661209319509107,0.266428461096317
205,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.0676667443527353,0.270704122804407
206,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0686094753509742,0.270704122804407
207,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.0689257649220572,0.270704122804407
208,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Down,0.0690182247130488,0.270704122804407
209,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.0691120028621698,0.270704122804407
210,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.0691579875777682,0.270704122804407
211,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0696339330402253,0.271275322080878
212,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0718255750371803,0.278443117974917
213,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.0724059435622026,0.278443117974917
214,WP_EGFEGFR_SIGNALING,141,Down,0.0728087829088857,0.278443117974917
215,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.0731854074254941,0.278443117974917
216,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.073421536361035,0.278443117974917
217,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.0735062732366873,0.278443117974917
218,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.0743849001473119,0.280478843674726
219,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.0773697725123388,0.289811180179467
220,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.077892389752831,0.289811180179467
221,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.078270172749199,0.289811180179467
222,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.078270172749199,0.289811180179467
223,WP_ACUTE_VIRAL_MYOCARDITIS,65,Down,0.0788553215804754,0.290668494794398
224,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.0793856687263329,0.291317052201097
225,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.0813522013010304,0.297206708753098
226,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.0830598826580516,0.29802357616003
227,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.0830598826580516,0.29802357616003
228,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.0833361857385735,0.29802357616003
229,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Down,0.0835108897162244,0.29802357616003
230,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.0836468690010208,0.29802357616003
231,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.0837511509646801,0.29802357616003
232,WP_NUCLEAR_RECEPTORS_METAPATHWAY,177,Down,0.0846582832351678,0.299550105626987
233,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.0849089715463357,0.299550105626987
234,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.0870810213129847,0.305899997945613
235,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0892581526285445,0.310563936908779
236,WP_INSULIN_SIGNALING,132,Down,0.0894848365532506,0.310563936908779
237,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0895421569919474,0.310563936908779
238,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.091818230755401,0.317120107903108
239,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0938585698039434,0.321924978772359
240,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.0939926945320756,0.321924978772359
241,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.0947042629793192,0.323016199871371
242,WP_TAR_SYNDROME,43,Down,0.095457863710898,0.324241173431232
243,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0962056487496305,0.325436392066651
244,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Down,0.0975741413538555,0.328712886036349
245,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0988193492855481,0.33002719976512
246,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.0990088605550348,0.33002719976512
247,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.0991687571070372,0.33002719976512
248,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.099785389148696,0.330740281775113
249,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Down,0.100704910686682,0.332144993777487
250,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.101017333873932,0.332144993777487
251,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.102534976568474,0.335791835614682
252,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.103225539914344,0.336711880196788
253,WP_GPCRS_OTHER,13,Down,0.103933701907319,0.337681829912316
254,WP_BURN_WOUND_HEALING,60,Down,0.1058915809532,0.341766409156976
255,WP_ATR_SIGNALING,10,Up,0.106022426198332,0.341766409156976
256,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.107242613248416,0.342061805497716
257,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.107566177193955,0.342061805497716
258,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.107778598082614,0.342061805497716
259,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.107778598082614,0.342061805497716
260,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.108862383198329,0.344172611496255
261,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.109858917211494,0.345992451907464
262,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.111658007666156,0.35031634466252
263,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.112387200360204,0.350468174420632
264,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Up,0.112559121711736,0.350468174420632
265,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.114717127724716,0.355839543357421
266,WP_PURINERGIC_SIGNALING,15,Down,0.116926025372244,0.360865312061359
267,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.117215375085624,0.360865312061359
268,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,136,Down,0.117921113212899,0.361683414406728
269,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.119510824525581,0.365196645948058
270,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.121265528529197,0.369186164633335
271,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.12288475638363,0.372735312720826
272,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.123583287623106,0.37347596480218
273,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.125968991923297,0.377324979011905
274,WP_AEROBIC_GLYCOLYSIS,10,Down,0.126631560610023,0.377324979011905
275,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.126631560610023,0.377324979011905
276,WP_SEROTONIN_AND_ANXIETY,8,Down,0.12703734434863,0.377324979011905
277,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.127330061902111,0.377324979011905
278,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.127611124288698,0.377324979011905
279,WP_PLEURAL_MESOTHELIOMA,255,Down,0.12830635104208,0.378020862209999
280,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.12952349711821,0.380243980825601
281,WP_CAMKK2_PATHWAY,30,Down,0.131239012194501,0.383909138875017
282,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.132963699197244,0.386484601318395
283,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.133059783665579,0.386484601318395
284,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.134380430486698,0.388946175563613
285,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.135355962584482,0.390395092085768
286,WP_NRF2_PATHWAY,71,Down,0.137550393100676,0.393021469041612
287,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.137959279950308,0.393021469041612
288,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.137973329325626,0.393021469041612
289,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.138179080964752,0.393021469041612
290,WP_THERMOGENESIS,74,Down,0.14185802524003,0.400707256538767
291,WP_ENERGY_METABOLISM,41,Down,0.142651527580194,0.400707256538767
292,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.143649418872766,0.400707256538767
293,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.143900813533417,0.400707256538767
294,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.144321914316267,0.400707256538767
295,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.144334313529232,0.400707256538767
296,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.145300500734761,0.400707256538767
297,WP_OVARIAN_INFERTILITY,21,Down,0.145440673505094,0.400707256538767
298,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.146267412341182,0.400707256538767
299,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.146747631050053,0.400707256538767
300,WP_PEPTIDE_GPCRS,15,Down,0.146768657738153,0.400707256538767
301,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.146793011212663,0.400707256538767
302,WP_VITAMIN_B12_METABOLISM,23,Down,0.147218481112783,0.400707256538767
303,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.148346396322859,0.4024446791333
304,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,73,Down,0.150019736586565,0.404013780896332
305,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,22,Down,0.150390882381845,0.404013780896332
306,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.150399290698635,0.404013780896332
307,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.151006136136507,0.404322618580485
308,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.153127850947432,0.40773341697433
309,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.153573216524487,0.40773341697433
310,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.154154903446924,0.40773341697433
311,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Up,0.154264103015835,0.40773341697433
312,WP_ARYLAMINE_METABOLISM,1,Up,0.155604084558402,0.408657748514069
313,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.155608120784554,0.408657748514069
314,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.156369208828417,0.409348693175029
315,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Down,0.158156412987281,0.410918722064335
316,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Up,0.15874201848675,0.410918722064335
317,WP_TCELL_RECEPTOR_SIGNALING,74,Down,0.158931055412418,0.410918722064335
318,WP_VITAMIN_D_METABOLISM,6,Down,0.15896855671102,0.410918722064335
319,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.159722901153521,0.411574372251392
320,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.161752654947563,0.415502132396553
321,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.162587825332101,0.41569660601798
322,WP_CREATINE_PATHWAY,2,Down,0.163224660863156,0.41569660601798
323,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.163345503337965,0.41569660601798
324,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.164360924579254,0.416989753099218
325,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.166261422697311,0.420513506022123
326,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.167501699957989,0.422350912164008
327,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.170290967785667,0.428070873149291
328,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.171487089156146,0.429763375873023
329,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.176078388469145,0.437440469334549
330,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.176361237391346,0.437440469334549
331,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.176596608502395,0.437440469334549
332,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.177056667818303,0.437440469334549
333,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.177419889181089,0.437440469334549
334,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.177743451043479,0.437440469334549
335,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.179608899839281,0.440711987068325
336,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.180822890539119,0.442370285783201
337,WP_SMALL_LIGAND_GPCRS,7,Down,0.182199612197165,0.443414599874845
338,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,16,Down,0.18232863109209,0.443414599874845
339,WP_KREBS_CYCLE_DISORDERS,11,Down,0.185459720294531,0.449698790802667
340,WP_INTEGRATED_CANCER_PATHWAY,41,Up,0.186801520164511,0.451620145809495
341,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.188887066844781,0.455041926093707
342,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.189647781064179,0.455041926093707
343,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.189877592031802,0.455041926093707
344,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.191072113347198,0.456573480149409
345,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.194831159741295,0.464206415383607
346,WP_PROLACTIN_SIGNALING,69,Down,0.197384782061661,0.465619927525583
347,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.197573753476332,0.465619927525583
348,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.197633522793732,0.465619927525583
349,WP_IRINOTECAN_PATHWAY,5,Up,0.197878201262233,0.465619927525583
350,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.198630535335028,0.465619927525583
351,WP_PURINE_METABOLISM,10,Down,0.199193789755453,0.465619927525583
352,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.199757396648223,0.465619927525583
353,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.199956002939818,0.465619927525583
354,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.203475092534751,0.472476062326456
355,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.205208773280855,0.475159469399614
356,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Down,0.206292174879617,0.476326313907431
357,WP_IL18_SIGNALING,191,Down,0.209311338534363,0.4819437542724
358,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.210540605913024,0.482412002180549
359,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.210688453507077,0.482412002180549
360,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.212625447633403,0.48379430128438
361,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.212992093325637,0.48379430128438
362,WP_GPR40_PATHWAY,9,Up,0.213057830979253,0.48379430128438
363,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.214379244585783,0.484668684681375
364,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Down,0.215286095240189,0.484668684681375
365,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.215453586633459,0.484668684681375
366,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.216500549828524,0.484668684681375
367,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,31,Down,0.216812721844873,0.484668684681375
368,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.217322034152854,0.484668684681375
369,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.217969815938444,0.484668684681375
370,WP_OSTEOPONTIN_SIGNALING,11,Down,0.218159870233709,0.484668684681375
371,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.219383935199055,0.486074379335911
372,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.221391544560062,0.487309020423357
373,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.221542214405064,0.487309020423357
374,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.221719675959046,0.487309020423357
375,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.222927961963829,0.488658092624714
376,WP_IL3_SIGNALING,46,Down,0.224589185248879,0.48983905580625
377,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.224658545059557,0.48983905580625
378,WP_WNT_SIGNALING_WP363,39,Down,0.228383836647159,0.496644216200964
379,WP_HEPATITIS_B_INFECTION,117,Down,0.229264992698669,0.497244918201335
380,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.231606676972846,0.499753838695843
381,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.231689964546683,0.499753838695843
382,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.232245701194418,0.499753838695843
383,WP_SMALL_CELL_LUNG_CANCER,70,Down,0.234032898902707,0.501642254227773
384,WP_PPAR_SIGNALING,39,Down,0.23468747031874,0.501642254227773
385,WP_NUCLEOTIDE_GPCRS,5,Up,0.236554707496425,0.501642254227773
386,WP_DRAVET_SYNDROME,15,Down,0.23720638899066,0.501642254227773
387,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.237358672872436,0.501642254227773
388,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.238047741263317,0.501642254227773
389,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.238429521216818,0.501642254227773
390,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.23849021673809,0.501642254227773
391,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.238648848319133,0.501642254227773
392,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.239225989850714,0.501642254227773
393,WP_IL19_SIGNALING,20,Down,0.241215163809079,0.504526373157921
394,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.243459811563606,0.507928845444884
395,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.244191904782649,0.508166444889461
396,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.245210239639364,0.50899701258474
397,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.247404662261807,0.512258519846865
398,WP_BARDETBIEDL_SYNDROME,65,Up,0.248899435074781,0.514058632239874
399,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.250768112535477,0.51662002131369
400,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.252692231328266,0.517998178683487
401,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.252697408335862,0.517998178683487
402,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.254609466179284,0.519061057236454
403,WP_HUNGER_AND_SATIETY,2,Up,0.255637055242667,0.519061057236454
404,WP_COMPLEMENT_SYSTEM,51,Up,0.255680393510739,0.519061057236454
405,WP_FERROPTOSIS,50,Down,0.255741761777085,0.519061057236454
406,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.25666894536615,0.519659785938363
407,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Down,0.257625181231949,0.519828935342632
408,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.258017281775905,0.519828935342632
409,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.259303774474381,0.52114352718323
410,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.260804061962334,0.52288033886107
411,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.261804219682832,0.523608439365663
412,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.263551779052641,0.525824180537065
413,WP_OREXIN_RECEPTOR_PATHWAY,119,Down,0.265076130009418,0.527494673752046
414,WP_RETINOBLASTOMA_GENE_IN_CANCER,73,Up,0.265861816393121,0.527494673752046
415,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.266676191396813,0.527494673752046
416,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.267282244740352,0.527494673752046
417,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.267597662961804,0.527494673752046
418,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.269420905031224,0.528988503030782
419,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.26964255811423,0.528988503030782
420,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.272980750505489,0.530712947836684
421,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.273093837893173,0.530712947836684
422,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,176,Down,0.273364144562358,0.530712947836684
423,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.273727031707676,0.530712947836684
424,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.274194811954181,0.530712947836684
425,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.274581060080075,0.530712947836684
426,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.275649614056428,0.530712947836684
427,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.27568665295166,0.530712947836684
428,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.278585736597358,0.535040830567824
429,WP_NUCLEAR_RECEPTORS,20,Down,0.279955214075076,0.536417682913082
430,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.281462059932644,0.537094963900528
431,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.281615485938111,0.537094963900528
432,WP_FOLATE_METABOLISM,36,Down,0.283610666977332,0.538568358986731
433,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.283764693582502,0.538568358986731
434,WP_GLUTATHIONE_METABOLISM,10,Down,0.284353610462581,0.538568358986731
435,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.289358069106108,0.546786971966024
436,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.293073190079888,0.552537069370798
437,WP_MALE_INFERTILITY,68,Up,0.295064680115662,0.55468058365333
438,WP_NRF2ARE_REGULATION,20,Up,0.295559727056154,0.55468058365333
439,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.298392119315572,0.558720551429158
440,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.300748297854761,0.561852501901395
441,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.301494496027321,0.561969332731197
442,WP_ATM_SIGNALING,34,Up,0.302219784806541,0.562046749119857
443,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.303814438326871,0.562943837115747
444,WP_ENDOMETRIAL_CANCER,49,Down,0.304071853624564,0.562943837115747
445,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.307427682410689,0.567877651554127
446,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.308467610167534,0.568350918324077
447,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.309066740256524,0.568350918324077
448,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.312319203961646,0.573049967983199
449,WP_BLADDER_CANCER,29,Down,0.313765879568061,0.574422167048877
450,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.315178749821868,0.575726516341279
451,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.316048987912938,0.576036071096308
452,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.317288252184887,0.577015361274286
453,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.320269957470458,0.580309549461983
454,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.320725109136552,0.580309549461983
455,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.321646704449864,0.580309549461983
456,WP_ESTROGEN_SIGNALING,21,Down,0.32192354568694,0.580309549461983
457,WP_IL9_SIGNALING,15,Up,0.32287390516832,0.580749124832296
458,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.329599111555865,0.589220070371953
459,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.330799325145409,0.589220070371953
460,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.330911393810424,0.589220070371953
461,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.332399079262231,0.589220070371953
462,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.333193192374934,0.589220070371953
463,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.334087209677033,0.589220070371953
464,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Down,0.334317127351136,0.589220070371953
465,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.334513106068889,0.589220070371953
466,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.334933002263798,0.589220070371953
467,WP_BENZENE_METABOLISM,3,Up,0.335203473422654,0.589220070371953
468,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.335468361233666,0.589220070371953
469,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.338661367145541,0.593560008088773
470,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Down,0.342545357432302,0.599089965551814
471,WP_G_PROTEIN_SIGNALING,62,Down,0.345846326554879,0.603578939337815
472,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.352830573074444,0.614459873570008
473,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.353576058635783,0.614459873570008
474,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.356537814943971,0.617998304945552
475,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.357428573270132,0.617998304945552
476,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.359067260867862,0.617998304945552
477,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.359221689365471,0.617998304945552
478,WP_P38_MAPK_SIGNALING,31,Down,0.360514748930462,0.617998304945552
479,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.360828232139804,0.617998304945552
480,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.360874922595943,0.617998304945552
481,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.361996485119927,0.618630167918045
482,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.367825273147994,0.627287084082264
483,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Down,0.374516463849006,0.637375845308247
484,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.377053391760437,0.640367537246032
485,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.378515496560681,0.641525233346143
486,WP_LEPTIN_SIGNALING,70,Down,0.382753499060671,0.645049554670221
487,WP_ALLOGRAFT_REJECTION,50,Down,0.382887224343484,0.645049554670221
488,WP_DNA_MISMATCH_REPAIR,21,Up,0.383102348407014,0.645049554670221
489,WP_DNA_DAMAGE_RESPONSE,59,Up,0.383733859165131,0.645049554670221
490,WP_RAS_SIGNALING,117,Down,0.384801718645674,0.645524515768865
491,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.386218085615345,0.64654708856133
492,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.387495648631151,0.64654708856133
493,WP_PHOSPHOINOSITIDES_METABOLISM,39,Up,0.387770942409654,0.64654708856133
494,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.391719299077975,0.651427666098059
495,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.392283083599196,0.651427666098059
496,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.393821649058242,0.652664103882812
497,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Down,0.39967477982231,0.661031527191024
498,WP_KININKALLIKREIN_PATHWAY,2,Down,0.401648197629661,0.662961482834501
499,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.405659115817635,0.668240066537266
500,WP_APOPTOSIS,72,Down,0.408251527282151,0.669974039274607
501,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,22,Up,0.408341841455691,0.669974039274607
502,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Down,0.410781714740073,0.67263460063016
503,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.412551042839957,0.674188781738458
504,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.413598079789133,0.67455877298942
505,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.414704427568895,0.675023840518082
506,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.416710991425923,0.676455337725885
507,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Down,0.417939723162043,0.676455337725885
508,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.418417097424769,0.676455337725885
509,WP_ADIPOGENESIS,86,Down,0.418967407074934,0.676455337725885
510,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.419698567202191,0.676455337725885
511,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.420919853450169,0.677096124336672
512,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.423957117178925,0.680649902970852
513,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.429934654614411,0.688901142481572
514,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.43199854152127,0.690861480798608
515,WP_ERBB_SIGNALING,69,Down,0.43634699526808,0.694927498817558
516,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.436405442760343,0.694927498817558
517,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.437077271154109,0.694927498817558
518,WP_PYRIMIDINE_METABOLISM,71,Down,0.439296781070061,0.697108019381448
519,WP_MATRIX_METALLOPROTEINASES,8,Down,0.441324757324212,0.698410919475124
520,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.441817126675261,0.698410919475124
521,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.444465718355091,0.701249175600547
522,WP_CILIARY_LANDSCAPE,185,Down,0.448050725086741,0.705551141803259
523,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.450076056036283,0.707385311781691
524,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.451025360098358,0.707524515268798
525,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.454136764021827,0.711048419097032
526,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.457172101883757,0.712324665965447
527,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.457203264469793,0.712324665965447
528,WP_4P163_COPY_NUMBER_VARIATION,22,Down,0.457551610255178,0.712324665965447
529,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.459125986546299,0.713199116587443
530,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.460658426345889,0.713199116587443
531,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.460716217649553,0.713199116587443
532,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.46253643204413,0.714670953271193
533,WP_NEPHROTIC_SYNDROME,27,Down,0.46482578046417,0.716860772122978
534,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.46638820870223,0.717923422384332
535,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.469225093416728,0.719706883760645
536,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.470323845839997,0.719706883760645
537,WP_SERINE_METABOLISM,5,Up,0.470496546194413,0.719706883760645
538,WP_TGFB_SMAD_SIGNALING,7,Down,0.471455289359349,0.719706883760645
539,WP_JOUBERT_SYNDROME,72,Up,0.471924586796822,0.719706883760645
540,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.474754133653649,0.721776806205532
541,WP_CILIOPATHIES,128,Up,0.475038019655952,0.721776806205532
542,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.477039704596965,0.722735137582516
543,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.477427225921297,0.722735137582516
544,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.482143490932402,0.728532995489769
545,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.483887847034864,0.728612504461375
546,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.48466838589106,0.728612504461375
547,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.484855279732813,0.728612504461375
548,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.486013318408301,0.729019977612451
549,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.4891743229626,0.730866027863701
550,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.489689617248103,0.730866027863701
551,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.490655310821701,0.730866027863701
552,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.491025443378022,0.730866027863701
553,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.492578807100353,0.730866027863701
554,WP_HEME_BIOSYNTHESIS,8,Down,0.492578807100353,0.730866027863701
555,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.493544803190815,0.730906398605469
556,WP_MONOAMINE_GPCRS,3,Down,0.494384376672312,0.730906398605469
557,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Up,0.496055943116139,0.732061014796169
558,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.498281971991492,0.732835201595034
559,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.499243118738725,0.732835201595034
560,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.499735601277421,0.732835201595034
561,WP_COPPER_HOMEOSTASIS,39,Up,0.500146652183472,0.732835201595034
562,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.502350154759594,0.734754140947307
563,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.506505363883759,0.739515824356039
564,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.50769247693724,0.739934780217041
565,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.509730924758974,0.741590832127215
566,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.511728099163536,0.741790178418972
567,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.512347232979753,0.741790178418972
568,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.512575208445226,0.741790178418972
569,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.517933100003388,0.746949021987182
570,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.51795735101301,0.746949021987182
571,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.519728424947435,0.748190482148497
572,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.521475236059911,0.748737169594271
573,WP_TP53_NETWORK,16,Up,0.521929924790167,0.748737169594271
574,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.525212421641946,0.751053704334551
575,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.525372116779035,0.751053704334551
576,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.526981969930786,0.751804564317966
577,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.527726561571127,0.751804564317966
578,WP_VITAMIN_B12_DISORDERS,9,Down,0.529132681010948,0.752388254261371
579,WP_KALLMANN_SYNDROME,11,Down,0.530776925495614,0.752388254261371
580,WP_RETINOL_METABOLISM,6,Down,0.530882223201454,0.752388254261371
581,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.532094105900838,0.752807840018054
582,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.533303596216293,0.75322260496528
583,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.53900678562636,0.758482032294622
584,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.539724082723644,0.758482032294622
585,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.539795606925005,0.758482032294622
586,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.54145114446042,0.759166667031865
587,WP_FRAGILE_X_SYNDROME,84,Down,0.543563536997544,0.759166667031865
588,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.543808895676417,0.759166667031865
589,WP_ECTODERM_DIFFERENTIATION,78,Down,0.543977088663952,0.759166667031865
590,WP_MTHFR_DEFICIENCY,18,Up,0.546948676892186,0.761187338241035
591,WP_FOXA2_PATHWAY,9,Down,0.54727702785943,0.761187338241035
592,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.551561328192598,0.765850357726885
593,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.552692258661397,0.766126537301296
594,WP_DOPAMINE_METABOLISM,7,Down,0.555133837621852,0.767972243818398
595,WP_WNT_SIGNALING_WP428,60,Down,0.555892317605775,0.767972243818398
596,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.557366168727383,0.768716427338773
597,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.558660546108408,0.769211003184441
598,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.560906160989722,0.77010270901822
599,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.561598049885909,0.77010270901822
600,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.56211876570673,0.77010270901822
601,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.566286921110788,0.774522211569164
602,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.570346072779674,0.778778192400153
603,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.572160686837045,0.7799603392704
604,WP_NRXN1_DELETION_SYNDROME,2,Up,0.576493870362807,0.784566161321568
605,WP_FOXP3_IN_COVID19,9,Up,0.578096559427635,0.785446895619035
606,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.579824859225215,0.785662002039795
607,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.580166466226467,0.785662002039795
608,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.582770553173607,0.786689412563135
609,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.582839236315023,0.786689412563135
610,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.586275649475296,0.790030465358514
611,WP_ENDODERM_DIFFERENTIATION,84,Down,0.590286387449506,0.794133241380514
612,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.592195321539892,0.795399598538874
613,WP_MONOAMINE_TRANSPORT,12,Down,0.595304654798623,0.798271494689182
614,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.598042291043938,0.800022485268839
615,WP_MELANOMA,55,Down,0.598556968905518,0.800022485268839
616,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.601864514153926,0.801889599612641
617,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.601904967105839,0.801889599612641
618,WP_MEASLES_VIRUS_INFECTION,100,Up,0.60443370455724,0.803955509945067
619,WP_GLYOXYLATE_METABOLISM,5,Down,0.606136271313375,0.804917633311137
620,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.609543432899693,0.80813661587669
621,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.612753045879713,0.811083741889088
622,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.614543054615509,0.812145322980624
623,WP_PPARALPHA_PATHWAY,15,Down,0.624958162581806,0.824583643085464
624,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.626405070011269,0.825168217226383
625,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.62885990583679,0.825824450725332
626,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.628912537900314,0.825824450725332
627,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.632205298310658,0.828110543476826
628,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.634285464910812,0.828110543476826
629,WP_5Q35_COPY_NUMBER_VARIATION,77,Down,0.634682206843023,0.828110543476826
630,WP_ONECARBON_METABOLISM,22,Up,0.634683263248663,0.828110543476826
631,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.637399908156416,0.829322000344195
632,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.638043132626287,0.829322000344195
633,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.639394107918057,0.829322000344195
634,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.639647382260608,0.829322000344195
635,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.640780851535061,0.829483244034363
636,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.64325949488379,0.831382554708295
637,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.647747385786499,0.835198656581631
638,WP_CANCER_PATHWAYS,308,Down,0.649022554331028,0.835198656581631
639,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.649260269532436,0.835198656581631
640,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.650908822680738,0.836011019130572
641,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.652553808325272,0.836816272142548
642,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.654224422449481,0.837651830612887
643,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.658891840278369,0.842315851802208
644,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.664053237022658,0.847578340880924
645,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.665070595946711,0.847578340880924
646,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.668242476109863,0.849149622034699
647,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.668369593012713,0.849149622034699
648,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.669767921876663,0.849613012010211
649,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.672677300773478,0.850832345888726
650,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.672799300276973,0.850832345888726
651,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.681544993160699,0.85833289574545
652,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.681830331972248,0.85833289574545
653,WP_CYTOSINE_METHYLATION,7,Down,0.681862993822116,0.85833289574545
654,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.68308830488307,0.858464806925169
655,WP_ZINC_HOMEOSTASIS,21,Down,0.684826323413074,0.858464806925169
656,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.68510086781376,0.858464806925169
657,WP_NONSMALL_CELL_LUNG_CANCER,61,Up,0.686520421013558,0.858934225377694
658,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.691491225227718,0.863838582275356
659,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.695469036182185,0.866879805051571
660,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.696808508559135,0.866879805051571
661,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.697089478271397,0.866879805051571
662,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.700655190825833,0.869997835134192
663,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.70378228509291,0.872562652106142
664,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.709526831254258,0.877267703605719
665,WP_IL6_SIGNALING,38,Up,0.709711706688325,0.877267703605719
666,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.715666594934194,0.883300211765627
667,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.71781980218869,0.883367025712176
668,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,65,Down,0.717870040359773,0.883367025712176
669,WP_CHOLESTASIS,9,Down,0.721325429981199,0.886292232353581
670,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.723388451665554,0.88629409993123
671,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.724466342537586,0.88629409993123
672,WP_BDNFTRKB_SIGNALING,27,Down,0.724608654701802,0.88629409993123
673,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Down,0.725639816610362,0.88629409993123
674,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.727782183840097,0.887074241598306
675,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.728436877224886,0.887074241598306
676,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Down,0.730019666298229,0.887686635646663
677,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Up,0.735232016224089,0.892591825672899
678,WP_PREIMPLANTATION_EMBRYO,21,Down,0.73640694343376,0.892591825672899
679,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.73731125259355,0.892591825672899
680,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.740949778289478,0.893624364451059
681,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.741099550369615,0.893624364451059
682,WP_IL11_SIGNALING,40,Up,0.741425567585915,0.893624364451059
683,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.744724712727446,0.896286550310338
684,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.746545003134882,0.897163731837533
685,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.749767282340979,0.898484441492412
686,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.749830081342816,0.898484441492412
687,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.75377823503216,0.901900595627999
688,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.759051437947853,0.906889944757464
689,WP_OSTEOCLAST_SIGNALING,9,Down,0.767568858928037,0.912259341225614
690,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.767698445677043,0.912259341225614
691,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.770663584789227,0.912259341225614
692,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.773855521410119,0.912259341225614
693,WP_SPINA_BIFIDA,10,Down,0.774385725708036,0.912259341225614
694,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.775831811775904,0.912259341225614
695,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.77682572214379,0.912259341225614
696,WP_BASE_EXCISION_REPAIR,29,Down,0.778126299257228,0.912259341225614
697,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.778950693330102,0.912259341225614
698,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.778973694954986,0.912259341225614
699,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.779914725320698,0.912259341225614
700,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.779914725320698,0.912259341225614
701,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.780195124689637,0.912259341225614
702,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.781137983198974,0.912259341225614
703,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.781485422673084,0.912259341225614
704,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.782764069592723,0.912259341225614
705,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.783495746808641,0.912259341225614
706,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.783522013266768,0.912259341225614
707,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.784691129445279,0.912328300430013
708,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.788038405805329,0.914027232629571
709,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.788376287024776,0.914027232629571
710,WP_TRYPTOPHAN_METABOLISM,19,Down,0.792750359014638,0.917803936774694
711,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.806311354743664,0.930937800398903
712,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.808202522991686,0.930937800398903
713,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.808380951866885,0.930937800398903
714,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.810586583065629,0.930937800398903
715,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.81115047776815,0.930937800398903
716,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.811304142512366,0.930937800398903
717,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Down,0.812022387939189,0.930937800398903
718,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.814169497403076,0.931009805712932
719,WP_PI3KAKT_SIGNALING,178,Up,0.814783057379054,0.931009805712932
720,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.815483041500379,0.931009805712932
721,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.819159522509517,0.932724934020466
722,WP_IL5_SIGNALING,37,Up,0.819254747399972,0.932724934020466
723,WP_EICOSANOID_SYNTHESIS,13,Up,0.821839680347798,0.933570333004116
724,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Up,0.82226876045618,0.933570333004116
725,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.823496664364457,0.933674838769081
726,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.826732288520276,0.934379482241114
727,WP_IRON_METABOLISM_DISORDERS,10,Up,0.828255536617561,0.934379482241114
728,WP_CELLULAR_PROTEOSTASIS,6,Up,0.82848464978321,0.934379482241114
729,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.828665015272229,0.934379482241114
730,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.833064953901064,0.938053961789965
731,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.837581637537785,0.940457742483012
732,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.838918338736012,0.940457742483012
733,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.842494616582958,0.940457742483012
734,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.842769470972787,0.940457742483012
735,WP_DNA_REPLICATION,36,Up,0.842846196356148,0.940457742483012
736,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.843516849710942,0.940457742483012
737,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.843946569514544,0.940457742483012
738,WP_MRNA_PROCESSING,124,Up,0.846047442617417,0.940457742483012
739,WP_METHYLATION_PATHWAYS,5,Up,0.84881933248657,0.940457742483012
740,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,48,Up,0.849492306692284,0.940457742483012
741,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.849960395058017,0.940457742483012
742,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.850754324979464,0.940457742483012
743,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.851402246150756,0.940457742483012
744,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.853189091537176,0.940457742483012
745,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.853391832901175,0.940457742483012
746,WP_KLEEFSTRA_SYNDROME,25,Up,0.853505445124485,0.940457742483012
747,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.855928990403351,0.941865636026177
748,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.85919605774951,0.944196737259488
749,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.860934710700064,0.944844235240925
750,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.862306554306892,0.945087983520354
751,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Up,0.86362577022589,0.945273479528205
752,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.865570510603826,0.946142233665352
753,WP_VALPROIC_ACID_PATHWAY,9,Down,0.866772576608952,0.946197952154792
754,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.868835758468722,0.947192299020277
755,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.872144732106072,0.948667022347035
756,WP_SILDENAFIL_TREATMENT,11,Up,0.873795104578047,0.948667022347035
757,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.874854982093988,0.948667022347035
758,WP_CELL_CYCLE,96,Up,0.8755564686076,0.948667022347035
759,WP_IL7_SIGNALING,23,Down,0.877638193245355,0.948667022347035
760,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.877721938409139,0.948667022347035
761,WP_STEROID_BIOSYNTHESIS,3,Up,0.879440712111631,0.948667022347035
762,WP_ALSTROM_SYNDROME,27,Up,0.880771139948521,0.948667022347035
763,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.881570939815079,0.948667022347035
764,WP_ID_SIGNALING,12,Up,0.881729446560992,0.948667022347035
765,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.883622396251545,0.948918689092588
766,WP_MIRNA_BIOGENESIS,6,Up,0.884272160395283,0.948918689092588
767,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.887272690537056,0.950897198984955
768,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.889865661403635,0.952434340721078
769,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.897897222078898,0.959780905785246
770,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.900328684152446,0.960900056571008
771,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.901282169849449,0.960900056571008
772,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.903247982547689,0.961748499552074
773,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.904841544488329,0.962198899831056
774,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.906908433737761,0.963150817225374
775,WP_IL2_SIGNALING,37,Down,0.910202919687947,0.963589956943981
776,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.91055204501576,0.963589956943981
777,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.910978104734465,0.963589956943981
778,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.912645410193108,0.963589956943981
779,WP_PDGFRBETA_PATHWAY,28,Up,0.913183183040586,0.963589956943981
780,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.91600528923004,0.9641680523428
781,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.916076945109156,0.9641680523428
782,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.919366760979345,0.966393193766012
783,WP_NEPHROGENESIS,4,Down,0.922119070873759,0.968048373254444
784,WP_IL17_SIGNALING,25,Up,0.923604135823185,0.968370662814615
785,WP_HIPPOYAP_SIGNALING,16,Down,0.929244394177927,0.973043174540454
786,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.931249075028526,0.973901704419145
787,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.936912191730561,0.978223626263992
788,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.937973224600753,0.978223626263992
789,WP_MACROPHAGE_MARKERS,8,Up,0.938951874844634,0.978223626263992
790,WP_G1_TO_S_CELL_CYCLE_CONTROL,52,Down,0.945359904178987,0.981676549782537
791,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.945997719035564,0.981676549782537
792,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.947752652929924,0.981676549782537
793,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.949238679284707,0.981676549782537
794,WP_IDO_METABOLIC_PATHWAY,8,Down,0.949650761833528,0.981676549782537
795,WP_GLUCURONIDATION,7,Down,0.950249100335345,0.981676549782537
796,WP_AUTOPHAGY,27,Down,0.950625953317396,0.981676549782537
797,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.953279342657938,0.981722017473832
798,WP_BREAST_CANCER_PATHWAY,88,Down,0.954214019425793,0.981722017473832
799,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.954252909928944,0.981722017473832
800,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Up,0.956207437995792,0.982503142540676
801,WP_TRANSSULFURATION_PATHWAY,8,Up,0.959353582363642,0.984505174410629
802,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.96262654341013,0.986480553719788
803,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,41,Down,0.963678691772494,0.986480553719788
804,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.965453116528637,0.987067738540472
805,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.966851751551806,0.987269738851658
806,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.96970507995861,0.988954808593024
807,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.972169895241508,0.990239967643766
808,WP_KIT_RECEPTOR_SIGNALING,52,Up,0.976866484822269,0.990421158354654
809,WP_TRANSLATION_FACTORS,49,Up,0.976889032147991,0.990421158354654
810,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.977733878460917,0.990421158354654
811,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.978069962673088,0.990421158354654
812,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.979004848368603,0.990421158354654
813,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.980500606647509,0.990421158354654
814,WP_GLIOBLASTOMA_SIGNALING,69,Down,0.980782022993538,0.990421158354654
815,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,28,Up,0.982105086244803,0.990540344654267
816,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.986973291858086,0.990627994808527
817,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.988701198982493,0.990627994808527
818,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Up,0.98886481735855,0.990627994808527
819,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.989295455456622,0.990627994808527
820,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.98942195440027,0.990627994808527
821,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.990016121090869,0.990627994808527
822,WP_IL4_SIGNALING,50,Down,0.990627994808527,0.990627994808527
